Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials
Zainul Abedin Kapacee, Jennifer J. Knox, Daniel H. Palmer, et al.
Medical Oncology (2020) Vol. 37, Iss. 7
Closed Access | Times Cited: 15

Showing 15 citing articles:

First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100335-100335
Open Access | Times Cited: 83
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
Edward Woods, Dat Tan Le, Bharath Kumar Jakka, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 28
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine
Liang Zhang, Kangjing Qi, Jie Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4150-4166
Closed Access | Times Cited: 11
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial
Hagen Schwenzer, Erica De Zan, Mustafa Elshani, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 23, pp. 6500-6513
Open Access | Times Cited: 27
Design, synthesis, and anti-cancer evaluation of the novel conjugate of gemcitabine's ProTide prodrug based on CD13
Liang Zhang, Geng Jia, Zhongqiang Li, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108293-108293
Closed Access
Stereoselective Synthesis of Nucleotide Analog Prodrugs (ProTides) via an Oxazaphospholidine Method
M. Nakamura, Kiyoshi Kakuta, Kazuki Sato, et al.
The Journal of Organic Chemistry (2025)
Open Access
2′-Fluorinated nucleoside chemistry for new drug discovery: achievements and prospects
Yonggang Meng, Nannan Sun, Lan Liang, et al.
National Science Review (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 3
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)
Mairéad G. McNamara, John Bridgewater, Daniel H. Palmer, et al.
The Oncologist (2020) Vol. 26, Iss. 4, pp. e669-e678
Open Access | Times Cited: 19
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells
R. Farrell, Harrison Steele, Ryan J. Middleton, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1973-1981
Open Access | Times Cited: 2
Expanding the toolbox of metabolically stable lipid prodrug strategies
Kiran S. Toti, Nicole Pribut, Michael P. D’Erasmo, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 5
Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review
Luke Bressler, Natalie Bath, Ashish Manne, et al.
Chinese Clinical Oncology (2023) Vol. 12, Iss. 2, pp. 15-15
Open Access | Times Cited: 4
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
Xingxing Xu, Zixuan Li, Xueying Yao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4
Moving forward in the treatment of cholangiocarcinoma
Tommaso Maria Manzia, Alessandro Parente, Ilaria Lenci, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 12, pp. 1939-1955
Open Access | Times Cited: 5
A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells
Xinlu Chai, Yuting Meng, Wei Ge, et al.
Journal of Biomedical Research (2023) Vol. 37, Iss. 5, pp. 355-355
Open Access | Times Cited: 1
Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture
Godefridus J. Peters
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 8, pp. 696-719
Closed Access
Page 1

Scroll to top